Luke Rothermel

10PUBLICATIONS

42CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Accounting theory and standardsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Social epidemiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 26, 2026

The Use and Utility of Adjuvant Checkpoint Inhibitors in Elderly Patients with Melanoma: A Single Institution Experience.

|May 20, 2026

Payer-Negotiated Prices in the Diagnosis and Management of Cutaneous Melanoma in 2025.

|Apr 30, 2026

Trends in Long-Term Survival Among Patients With De Novo Metastatic Cancer.

|Dec 31, 2025

Myocarditis Mimicking Takotsubo Cardiomyopathy With First Dose of Neoadjuvant Nivolumab-Relatlimab.

Rohit Rao, Felicia Tejawinata, Tejasi Sachdeva

|Sep 30, 2024

Accounting for Socioeconomic Factors and Selection Bias That Affect Survival for Patients With Early-Stage Melanoma.

Hailey Seibert, Hanna Kakish, Jeremy S Bordeaux

|Jul 22, 2024

The Utility of Sentinel Lymph Node Biopsy in Elderly Patients with Melanoma.

Hanna Kakish, Carmen A Jung, Susan J Doh

Pageof 2

Frequent Collaborators

Richard S Hoehn

Jonathan J Hue

Ankit Mangla

Jatin Narang

John B Ammori

Mehrdad Zarei

Omid Hajihassani

Alexander W Loftus

Nicholas G Zaorsky

Faith Nakazzi

Frequent Collaborators

Richard S Hoehn

Jonathan J Hue

Ankit Mangla

Jatin Narang